Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

18.25 -0.16 (-0.87%)
Streaming Delayed Price Updated: 10:36 AM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Fulgent Genetics's Return On Invested Capital Insights
Pulled from Benzinga Pro data, Fulgent Genetics (NASDAQ:FLGT) posted Q2 earnings of $11.10 million, an increase from Q1 of 92.77%. Sales dropped to $125.34 million, a 60.86% decrease between quarters. 
Via Benzinga
Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Fulgent Genetics, Inc. (FLGT)
From Kirby McInerney LLP
Via Business Wire
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Why Fulgent Genetics Shares Are Trading Higher Today
 
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Recap: Fulgent Genetics Q4 Earnings
Fulgent Genetics (NASDAQ:FLGT) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Recap: Fulgent Genetics Q2 Earnings
Fulgent Genetics (NASDAQ:FLGT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat... 
Via Benzinga
Fulgent Genetics Reports Second Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics Announces Launch of PCR Based Test to Detect Monkeypox
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics to Announce Second Quarter 2022 Financial Results on Thursday, August 4, 2022
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics: Q1 Earnings Insights
Fulgent Genetics (NASDAQ:FLGT) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat estimated... 
Via Benzinga
Fulgent Genetics Reports First Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics Announces Promotions and Leadership Updates
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics Announces Opening of New State-of-the-Art Oncology Laboratory in El Monte, California
From Fulgent Genetics, Inc.
Via Business Wire
Earnings Outlook For Fulgent Genetics
Fulgent Genetics (NASDAQ:FLGT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Fulgent... 
Via Benzinga
Fulgent Genetics Agrees to Acquire Inform Diagnostics and Provides Preliminary First Quarter Revenue Results
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics to Announce First Quarter 2022 Financial Results on Tuesday, May 3, 2022
From Fulgent Genetics, Inc.
Via Business Wire
These Are Ten Small Cap Stocks With Strong Buy Recommendations
One can reduce some risk by taking into account analyst recommendations. Stocks with strong buy recommendations are more likely to perform better than others. Let’s take a look at ten small cap stocks... 
Via Talk Markets
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (... 
Via Benzinga
Fulgent Genetics Announces Strategic Investment in Spatial Genomics
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics Reports Fourth Quarter and Full Year 2021 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase... 
Via Benzinga
Fulgent Genetics to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday February 23, 2022
From Fulgent Genetics, Inc.
Via Business Wire
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.